Cargando…
A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification
Betulinic acid (BA) is a natural product that exerts its cytotoxicity against various malignant carcinomas without side effects by triggering the mitochondrial pathway to apoptosis. Betulin (BE), the 28-hydroxyl analog of BA, is present in large amounts (up to 30% dry weight) in the outer bark of bi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270193/ https://www.ncbi.nlm.nih.gov/pubmed/23973995 http://dx.doi.org/10.3390/molecules180910228 |
_version_ | 1783376641494351872 |
---|---|
author | Ding, Weimin Sun, Miao Luo, Shaman Xu, Tao Cao, Yibo Yan, Xiufeng Wang, Yang |
author_facet | Ding, Weimin Sun, Miao Luo, Shaman Xu, Tao Cao, Yibo Yan, Xiufeng Wang, Yang |
author_sort | Ding, Weimin |
collection | PubMed |
description | Betulinic acid (BA) is a natural product that exerts its cytotoxicity against various malignant carcinomas without side effects by triggering the mitochondrial pathway to apoptosis. Betulin (BE), the 28-hydroxyl analog of BA, is present in large amounts (up to 30% dry weight) in the outer bark of birch trees, and shares the same pentacyclic triterpenoid core as BA, yet exhibits no significant cytotoxicity. Topomer CoMFA studies were performed on 37 BA and BE derivatives and their in vitro anti-cancer activity results (reported as IC(50) values) against HT29 human colon cancer cells in the present study. All derivatives share a common pentacyclic triterpenoid core and the molecules were split into three pieces by cutting at the C-3 and C-28 sites with a consideration toward structural diversity. The analysis gave a leave-one-out cross-validation q(2) value of 0.722 and a non-cross-validation r(2) value of 0.974, which suggested that the model has good predictive ability (q(2) > 0.2). The contour maps illustrated that bulky and electron-donating groups would be favorable for activity at the C-28 site, and a moderately bulky and electron-withdrawing group near the C-3 site would improve this activity. BE derivatives were designed and synthesized according to the modeling result, whereby bulky electronegative groups (maleyl, phthalyl, and hexahydrophthalyl groups) were directly introduced at the C-28 position of BE. The in vitro cytotoxicity values of the given analogs against HT29 cells were consistent with the predicted values, proving that the present topomer CoMFA model is successful and that it could potentially guide the synthesis of new betulinic acid derivatives with high anti-cancer activity. The IC(50) values of these three new compounds were also assayed in five other tumor cell lines. 28-O-hexahydrophthalyl BE exhibited the greatest anti-cancer activities and its IC(50) values were lower than those of BA in all cell lines, excluding DU145 cells. |
format | Online Article Text |
id | pubmed-6270193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62701932018-12-18 A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification Ding, Weimin Sun, Miao Luo, Shaman Xu, Tao Cao, Yibo Yan, Xiufeng Wang, Yang Molecules Article Betulinic acid (BA) is a natural product that exerts its cytotoxicity against various malignant carcinomas without side effects by triggering the mitochondrial pathway to apoptosis. Betulin (BE), the 28-hydroxyl analog of BA, is present in large amounts (up to 30% dry weight) in the outer bark of birch trees, and shares the same pentacyclic triterpenoid core as BA, yet exhibits no significant cytotoxicity. Topomer CoMFA studies were performed on 37 BA and BE derivatives and their in vitro anti-cancer activity results (reported as IC(50) values) against HT29 human colon cancer cells in the present study. All derivatives share a common pentacyclic triterpenoid core and the molecules were split into three pieces by cutting at the C-3 and C-28 sites with a consideration toward structural diversity. The analysis gave a leave-one-out cross-validation q(2) value of 0.722 and a non-cross-validation r(2) value of 0.974, which suggested that the model has good predictive ability (q(2) > 0.2). The contour maps illustrated that bulky and electron-donating groups would be favorable for activity at the C-28 site, and a moderately bulky and electron-withdrawing group near the C-3 site would improve this activity. BE derivatives were designed and synthesized according to the modeling result, whereby bulky electronegative groups (maleyl, phthalyl, and hexahydrophthalyl groups) were directly introduced at the C-28 position of BE. The in vitro cytotoxicity values of the given analogs against HT29 cells were consistent with the predicted values, proving that the present topomer CoMFA model is successful and that it could potentially guide the synthesis of new betulinic acid derivatives with high anti-cancer activity. The IC(50) values of these three new compounds were also assayed in five other tumor cell lines. 28-O-hexahydrophthalyl BE exhibited the greatest anti-cancer activities and its IC(50) values were lower than those of BA in all cell lines, excluding DU145 cells. MDPI 2013-08-22 /pmc/articles/PMC6270193/ /pubmed/23973995 http://dx.doi.org/10.3390/molecules180910228 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Ding, Weimin Sun, Miao Luo, Shaman Xu, Tao Cao, Yibo Yan, Xiufeng Wang, Yang A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification |
title | A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification |
title_full | A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification |
title_fullStr | A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification |
title_full_unstemmed | A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification |
title_short | A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification |
title_sort | 3d qsar study of betulinic acid derivatives as anti-tumor agents using topomer comfa: model building studies and experimental verification |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270193/ https://www.ncbi.nlm.nih.gov/pubmed/23973995 http://dx.doi.org/10.3390/molecules180910228 |
work_keys_str_mv | AT dingweimin a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification AT sunmiao a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification AT luoshaman a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification AT xutao a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification AT caoyibo a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification AT yanxiufeng a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification AT wangyang a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification AT dingweimin 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification AT sunmiao 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification AT luoshaman 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification AT xutao 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification AT caoyibo 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification AT yanxiufeng 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification AT wangyang 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification |